首頁 > 市場調查報告書 > 醫療設備

細胞冷凍保存市場規模、佔有率及成長分析（按產品、應用、最終用途及地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900334

細胞冷凍保存市場規模、佔有率及成長分析（按產品、應用、最終用途及地區分類）－2026-2033年產業預測

Cell Cryopreservation Market Size, Share, and Growth Analysis, By Product (Cell Freezing Media, Equipment), By Application (Stem Cells, Oocytes and Embryotic cells), By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 245 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，細胞冷凍保存市場規模將達到 107.8 億美元，到 2025 年將達到 132.1 億美元，到 2033 年將達到 669.6 億美元，在預測期（2026-2033 年）內複合年成長率為 22.5%。

細胞冷凍保存已成為在極低溫度下保存生物材料的重要方法，它能維持細胞代謝惰性的狀態，從而避免冰晶形成和細胞損傷。該技術尤其適用於保存幹細胞和活性組織，這些組織在基礎研究和醫學應用方面具有巨大的潛力。冷凍過程中的挑戰，例如冰晶形成和滲透壓衝擊，如果處理不當，會導致細胞死亡。因此，冷凍保存已成為長期保存的重要解決方案。冷凍保護劑和溫度控制技術的創新提高了該過程的有效性。此外，使用冷凍保存的細胞可以進行廣泛的移植性品質檢測，而無需獲取新鮮樣本。

細胞冷凍保存市場促進因素

由於慢性病發病率上升和新型病毒的出現，全球細胞冷凍保存市場預計將迎來顯著成長。科學家和臨床醫生對幹細胞研究的深入探索，也推動了這項需求的激增。世界各地的教育機構透過津貼博士生、臨床研究員和博士後研究人員，支持幹細胞研究領域的創新。此外，各國政府為促進製藥和生物製藥領域的研究而推出的各項舉措，也進一步推動了細胞冷凍保存市場的擴張，凸顯了其在推進醫療解決方案方面發揮的關鍵作用。

限制細胞冷凍保存市場的因素

由於有其他具有類似療效的替代療法，細胞冷凍保存市場的發展面臨嚴峻挑戰。這些替代療法可能會吸引潛在用戶，並轉移他們對冷凍保存技術的興趣。此外，儲存和維護冷凍保存細胞的高成本也對許多生產者構成障礙，使他們難以投資這項技術。這些經濟障礙可能會限制冷凍保存服務的普及，並最終阻礙市場擴張和應用。因此，競爭格局和經濟因素在塑造細胞冷凍保存市場的發展趨勢中發揮關鍵作用。

細胞冷凍保存市場趨勢

細胞冷凍保存市場正經歷著向玻璃化冷凍等先進技術的重大轉變，這些技術強調使用高濃度冷凍保護劑進行快速冷凍。這種創新方法透過即時暴露於液態氮中來避免冰晶形成，從而顯著提高細胞活力。雖然減少冰晶形成的好處顯而易見，但市場也意識到高濃度冷凍保護劑可能帶來的毒性問題。隨著研發工作不斷致力於最佳化這些技術，對高效安全的細胞保存解決方案的需求預計將持續成長，玻璃化冷凍技術也因此成為不斷發展的細胞冷凍保存領域的關鍵技術。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Thermo Fisher Scientific（US）
Merck KGaA（Germany）
GE Healthcare（US）
BioLife Solutions, Inc.（US）
Cook Medical（US）
FUJIFILM Irvine Scientific（US）
Lonza（Switzerland）
Sartorius AG（Germany）
Cytiva（US）
Corning Incorporated（US）
STEMCELL Technologies Inc.（Canada）
PromoCell GmbH（Germany）
Bio-Techne Corporation（US）
HiMedia Laboratories Pvt. Ltd.（India）
Miltenyi Biotec（Germany）
Takara Bio Inc.（Japan）
ReproCELL Inc.（Japan）
Core Dynamics, LLC（US）
Chart Industries, Inc.（US）
Worthington Industries（US）

結論與建議

簡介目錄

Product Code: SQMIG35J2037

Cell Cryopreservation Market size was valued at USD 10.78 Billion in 2024 and is poised to grow from USD 13.21 Billion in 2025 to USD 66.96 Billion by 2033, growing at a CAGR of 22.5% during the forecast period (2026-2033).

Cell cryopreservation is gaining traction as a crucial method for preserving biological materials at cryogenic temperatures while maintaining metabolic inactivity, which is essential for avoiding ice crystal formation and cellular damage. This technique is particularly valuable for storing stem cells and viable tissues, which have significant potential for basic research and medical applications. The challenges of freezing processes, such as crystal formation and osmotic shock, can lead to cell death if not managed properly. As a result, cryopreservation has emerged as an indispensable solution for long-term storage. Innovations in cryoprotective agents and temperature control technologies have enhanced the effectiveness of this process. Additionally, the availability of cryopreserved cells allows extensive quality testing for transplantation suitability without sourcing fresh samples.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cell Cryopreservation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cell Cryopreservation Market Segments Analysis

Global Cell Cryopreservation Market is segmented by Product, Application, End Use and region. Based on Product, the market is segmented into Cell Freezing Media, Equipment and Consumables. Based on Application, the market is segmented into Stem Cells, Oocytes and Embryotic cells, Sperm Cells, Hepatocytes and Others. Based on End Use, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, Research Institutes, Biobanks, IVF clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Cell Cryopreservation Market

The global cell cryopreservation market is poised for significant growth, driven by the increasing prevalence of chronic diseases and the emergence of new viruses. This surge in demand is complemented by a robust focus on stem cell research, as scientists and clinicians delve deeper into its potential. Educational institutions worldwide are supporting this initiative by providing grants to PhD candidates, Clinical Research Fellows, and postdoctoral researchers, fostering innovation in stem cell studies. Additionally, various government initiatives aimed at promoting research within the pharmaceutical and biopharmaceutical sectors are further propelling the expansion of the cell cryopreservation market, highlighting its critical role in advancing healthcare solutions.

Restraints in the Cell Cryopreservation Market

The growth of the cell cryopreservation market faces significant challenges due to the presence of alternative therapies that provide similar benefits. These alternatives may attract potential users, diverting interest from cryopreservation techniques. Additionally, the high costs associated with storage and maintenance of cryopreserved cells can be a deterrent for many producers, making it difficult for them to invest in this technology. These financial barriers can limit the accessibility of cryopreservation services, ultimately hindering market expansion and adoption. As a result, the competitive landscape and economic considerations play crucial roles in shaping the dynamics of the cell cryopreservation market.

Market Trends of the Cell Cryopreservation Market

The cell cryopreservation market is experiencing a notable shift towards advanced techniques such as vitrification, emphasizing rapid freezing methodologies that utilize high concentrations of cryoprotectants. This innovative approach circumvents the formation of ice crystals through immediate exposure to liquid nitrogen, significantly enhancing cell viability. While the benefits of reduced ice formation are evident, the market is also acknowledging concerns regarding potential toxicity associated with concentrated cryoprotectants. As research and development continue to focus on optimizing these techniques, the demand for effective and safe cell preservation solutions is poised for sustained growth, positioning vitrification as a key player in the evolving landscape of cellular cryopreservation.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Analysis

Global Cell Cryopreservation Market Size by Product & CAGR (2026-2033)

Market Overview
Cell Freezing Media
- Ethylene Glycol
- Dimethyl Sulfoxide
- Glycerol
- Others
Equipment
- Freezers
- Incubators
- Liquid Nitrogen Supply Tanks
Consumables
- Cryogenic vials
- Cryogenic tubes
- Cooler boxes/containers
- Others

Global Cell Cryopreservation Market Size by Application & CAGR (2026-2033)

Market Overview
Stem Cells
Oocytes and Embryotic cells
Sperm Cells
Hepatocytes
Others

Global Cell Cryopreservation Market Size by End Use & CAGR (2026-2033)

Market Overview
Biopharmaceutical & Pharmaceutical Companies
Research Institutes
Biobanks
IVF clinics
Others

Global Cell Cryopreservation Market Size & CAGR (2026-2033)

North America (Product, Application, End Use)
- US
- Canada
Europe (Product, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Product, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Product, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Product, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Thermo Fisher Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLife Solutions, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
FUJIFILM Irvine Scientific (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lonza (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sartorius AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cytiva (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Corning Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
STEMCELL Technologies Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PromoCell GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HiMedia Laboratories Pvt. Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ReproCELL Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Core Dynamics, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Chart Industries, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Worthington Industries (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments